| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2017 | Sheridan William P67 | Senior VP - CMO | Sell | 64,310 | $4.72 | $303,543.20 | -72.9% | |
| Sep 18, 2017 | Cohen Fred E | Director | Sale+OE | 54,250 | $5.42 | $294,035.00 | -31.2% | |
| Mar 20, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $9.20 | $29,900.00 | -2.2% | |
| Mar 10, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $9.06 | $29,445.00 | -2.7% | |
| Mar 8, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 6,500 | $8.43 | $54,762.50 | -2.7% | |
| Mar 6, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $7.90 | $25,675.00 | -2.7% | |
| Dec 19, 2016 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $7.45 | $24,212.50 | -2.6% | |
| Sep 14, 2016 | Barnes Alane P70 | VP, General Counsel &Corp Sec | Sell | 8,357 | $4.27 | $35,684.39 | -9.5% | |
| Aug 25, 2016 | Babu Yarlagadda S66 | Senior VP - Drug Discovery | Sell | 30,000 | $4.06 | $121,800.00 | -21.2% | |
| Aug 16, 2016 | Baker Bros. Advisors LP59 | 10% Owner | Sell | 4,046,590 | $5.00 | $20,251,102.77 | -8.2% |